LOCOREGIONAL RECURRENCE
Clinical trials for LOCOREGIONAL RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new LOCOREGIONAL RECURRENCE trials appear
Sign up with your email to follow new studies for LOCOREGIONAL RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug cocktail aims to stop breast cancer recurrence
Disease control Recruiting nowThis study is for people with a type of breast cancer (hormone receptor-positive, HER2-negative) that has come back in the same area after initial treatment. The goal is to see if adding the drug ribociclib to standard hormone therapy can help prevent the cancer from returning ag…
Matched conditions: LOCOREGIONAL RECURRENCE
Phase: PHASE2 • Sponsor: Oana Danciu • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
Can a targeted pill stop breast Cancer's return? new trial hopes so.
Disease control Recruiting nowThis study tests whether adding the drug abemaciclib to standard hormone therapy can help prevent breast cancer from coming back in people whose cancer has already returned in the same area (chest, breast, or nearby lymph nodes). About 290 participants will receive either hormone…
Matched conditions: LOCOREGIONAL RECURRENCE
Phase: PHASE3 • Sponsor: Japanese Foundation for Cancer Research • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Heat or no heat? new study tackles breast cancer recurrence treatment
Knowledge-focused Recruiting nowThis study follows 500 breast cancer patients whose cancer has returned in the same area. They will receive additional radiation therapy, some with and some without hyperthermia (heat treatment). The goal is to compare side effects, quality of life, and cancer control over five y…
Matched conditions: LOCOREGIONAL RECURRENCE
Sponsor: Amsterdam UMC, location VUmc • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC